Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7269 | 1311 | 32.1 | 68% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1046 | 9602 | OPIOID GROWTH FACTOR//OPIOID GROWTH FACTOR RECEPTOR//BETA ENDORPHIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DADLE | Author keyword | 13 | 45% | 2% | 22 |
2 | MOL BIOL DRUG | Address | 11 | 100% | 0% | 6 |
3 | KEY DISCIPLINE CELL BIOL | Address | 7 | 39% | 1% | 14 |
4 | U50 488H | Author keyword | 5 | 25% | 1% | 18 |
5 | K OPIOID RECEPTOR | Author keyword | 2 | 33% | 0% | 6 |
6 | U50 | Author keyword | 2 | 36% | 0% | 5 |
7 | ANTAGONISTS OPIOID | Author keyword | 2 | 67% | 0% | 2 |
8 | H 3 DAGO | Author keyword | 2 | 67% | 0% | 2 |
9 | ICA CELL | Author keyword | 2 | 67% | 0% | 2 |
10 | MYOCYTE VENTRICULAR | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DADLE | 13 | 45% | 2% | 22 | Search DADLE | Search DADLE |
2 | U50 488H | 5 | 25% | 1% | 18 | Search U50+488H | Search U50+488H |
3 | K OPIOID RECEPTOR | 2 | 33% | 0% | 6 | Search K+OPIOID+RECEPTOR | Search K+OPIOID+RECEPTOR |
4 | U50 | 2 | 36% | 0% | 5 | Search U50 | Search U50 |
5 | ANTAGONISTS OPIOID | 2 | 67% | 0% | 2 | Search ANTAGONISTS+OPIOID | Search ANTAGONISTS+OPIOID |
6 | H 3 DAGO | 2 | 67% | 0% | 2 | Search H+3+DAGO | Search H+3+DAGO |
7 | ICA CELL | 2 | 67% | 0% | 2 | Search ICA+CELL | Search ICA+CELL |
8 | MYOCYTE VENTRICULAR | 2 | 67% | 0% | 2 | Search MYOCYTE++VENTRICULAR | Search MYOCYTE++VENTRICULAR |
9 | 488H | 2 | 29% | 0% | 5 | Search 488H | Search 488H |
10 | INBRED WKY RATS | 2 | 29% | 0% | 5 | Search INBRED+WKY+RATS | Search INBRED+WKY+RATS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTACT RAT HEART | 35 | 60% | 3% | 38 |
2 | HIBERNATION INDUCTION TRIGGERS | 18 | 83% | 1% | 10 |
3 | NATURAL HIBERNATION | 15 | 88% | 1% | 7 |
4 | CANINE SINOATRIAL NODE | 14 | 100% | 1% | 7 |
5 | U50 488H | 12 | 75% | 1% | 9 |
6 | H 3 U69593 BINDING | 11 | 100% | 0% | 6 |
7 | ENKEPHALIN PEPTIDES | 9 | 67% | 1% | 8 |
8 | U69593 BINDING SITES | 8 | 100% | 0% | 5 |
9 | MORPHINE MIMICS | 7 | 67% | 0% | 6 |
10 | NALOXONE BLOCKADE | 6 | 80% | 0% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Effects of morphine on brain plasticity | 2015 | 1 | 37 | 19% |
Opioids and cardioprotection | 2001 | 116 | 179 | 48% |
Neuroprotection against hypoxia/ischemia: delta-opioid receptor-mediated cellular/molecular events | 2013 | 9 | 123 | 37% |
The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system | 2002 | 62 | 176 | 44% |
Opioid-induced preconditioning: Recent advances and future perspectives | 2005 | 67 | 82 | 38% |
Cardiac opioids | 2000 | 39 | 70 | 69% |
Cross-talk of oploid peptide receptor and beta-adrenergic receptor signalling in the heart | 2004 | 38 | 116 | 47% |
Opioids: Old drugs for potential new applications | 2005 | 44 | 76 | 38% |
Non-Analgesic Effects of Opioids: Cardiovascular Effects of Opioids and their Receptor Systems | 2012 | 5 | 174 | 57% |
THE OPIOID-PEPTIDES - A ROLE IN HYPERTENSION | 1987 | 66 | 50 | 78% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL BIOL DRUG | 11 | 100% | 0.5% | 6 |
2 | KEY DISCIPLINE CELL BIOL | 7 | 39% | 1.1% | 14 |
3 | ANAESTHESIA PHARMACOL THER EUT | 1 | 50% | 0.2% | 2 |
4 | HADASSAH MED BACTERIOL | 1 | 100% | 0.2% | 2 |
5 | CELLULAR PATHOBIOL UNIT | 1 | 17% | 0.3% | 4 |
6 | ANAL CLIN ESPECIALIZADOS | 1 | 50% | 0.1% | 1 |
7 | CARDIOVASC INTENS UNIT | 1 | 50% | 0.1% | 1 |
8 | EXPT ANAESTHESIOL CELLULAR PHYSIOL EA3212 | 1 | 50% | 0.1% | 1 |
9 | OLA B WILLIAMS GLAUCOMA HEWITT | 1 | 50% | 0.1% | 1 |
10 | PL BIOL PATHOL | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000248439 | RABBIT CONSCIOUS//CENTRAL HYPERTENSIVE AGENT//THORACIC ELECTRICAL IMPEDANCE |
2 | 0.0000114843 | PROENKEPHALIN//PROENKEPHALINS//PRO ENKEPHALIN |
3 | 0.0000113284 | INT HLTH EXERCISE//ANGER MANAGEMENT STYLE//RISK FOR HYPERTENSION |
4 | 0.0000112466 | DYNORPHIN//CI 977//DYNORPHIN A |
5 | 0.0000103389 | EA 4468GERIATR//EUROPEAN STUDY DIABET CEED//BETA ENDORPHIN LIKE IMMUNOREACTIVITY |
6 | 0.0000088945 | HYPOXIC SURVIVAL//AIRTIGHT CHAMBER//ANIMAL CAT |
7 | 0.0000065942 | POSTCONDITIONING//ISCHEMIC POSTCONDITIONING//REMOTE ISCHEMIC PRECONDITIONING |
8 | 0.0000064194 | DELTA OPIOID RECEPTOR//DELTA OPIOID AGONIST//SNC80 |
9 | 0.0000063943 | BUILDUP PROCESS//DELTA OPIATE RECEPTORS//DNA INTERACTION AND FRAGMENTATION |
10 | 0.0000059359 | 3RD MESSENGER//LEARNED HELPLESSNESS BEHAVIOR//MARKER ENZYME |